Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

6 structures for P43003

Entry ID Method Resolution Chain Position Source
5LLM X-ray 325 A PDB
5LLU X-ray 332 A PDB
5LM4 X-ray 310 A PDB
5MJU X-ray 371 A PDB
7NPW EM 399 A A/B/C 29-497 PDB
AF-P43003-F1 Predicted AlphaFoldDB

351 variants for P43003

Variant ID(s) Position Change Description Diseaes Association Provenance
rs754763002
RCV000279440
RCV000175770
CA241530
10 K>E Episodic ataxia type 6 [ClinVar] Yes ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
RCV002489481
RCV000993022
CA3235319
rs199774340
23 R>H Episodic ataxia type 6 [ClinVar] Yes ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
RCV000315656
RCV002520369
rs146939026
CA3235322
27 L>F Episodic ataxia type 6 [ClinVar] Yes ClinGen
ClinVar
ESP
ExAC
TOPMed
dbSNP
gnomAD
rs767138995
RCV001329184
70 P>R Episodic ataxia type 6 [ClinVar] Yes ClinVar
dbSNP
rs573483474
RCV000280466
CA3235396
RCV000713365
71 Y>C Episodic ataxia type 6 [ClinVar] Yes ClinGen
ClinVar
1000Genomes
ExAC
TOPMed
dbSNP
gnomAD
CA3235398
RCV002472994
rs148490778
RCV000340195
76 R>Q Episodic ataxia type 6 [ClinVar] Yes ClinGen
ClinVar
ESP
ExAC
TOPMed
dbSNP
gnomAD
CA3235451
rs764799721
RCV002523520
RCV000286063
125 V>A Episodic ataxia type 6 [ClinVar] Yes ClinGen
ClinVar
ExAC
dbSNP
gnomAD
RCV000765840
RCV000490058
CA3235463
rs774420370
170 F>L Episodic ataxia type 6 [ClinVar] Yes ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
RCV000010049
rs137852620
CA254817
186 C>S Episodic ataxia type 6 [ClinVar] Yes ClinGen
ClinVar
TOPMed
dbSNP
CA3235502
rs748235513
RCV000345659
201 V>M Episodic ataxia type 6 [ClinVar] Yes ClinGen
ClinVar
ExAC
dbSNP
gnomAD
RCV001155514
CA3235510
rs146815724
RCV000998370
209 L>V Episodic ataxia type 6 [ClinVar] Yes ClinGen
ClinVar
ESP
ExAC
dbSNP
gnomAD
rs761385978
RCV001155515
CA3235511
214 I>T Episodic ataxia type 6 [ClinVar] Yes ClinGen
ClinVar
ExAC
dbSNP
gnomAD
RCV001882488
RCV001155516
CA3235513
rs772789166
217 V>A Episodic ataxia type 6 [ClinVar] Yes ClinGen
ClinVar
ExAC
dbSNP
gnomAD
CA155219
RCV000396581
rs2032892
VAR_011877
RCV000993021
RCV000118364
219 E>D Episodic ataxia type 6 [ClinVar] Yes ClinGen
ClinVar
UniProt
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
RCV002520370
RCV000516272
rs201069745
CA3235521
RCV000310841
226 R>G Episodic ataxia type 6 [ClinVar] Yes ClinGen
ClinVar
ESP
ExAC
TOPMed
dbSNP
gnomAD
CA117053926
RCV001288773
RCV003135917
rs145397429
257 I>T Episodic ataxia type 6 [ClinVar] Yes ClinGen
ClinVar
ESP
TOPMed
dbSNP
RCV000993023
COSM1067632
RCV003160121
rs1371499415
CA359479395
268 R>K Variant assessed as Somatic; 0.0 impact. endometrium Inborn genetic diseases [NCI-TCGA, Cosmic, ClinVar] Yes ClinGen
cosmic curated
ClinVar
NCI-TCGA
TOPMed
dbSNP
gnomAD
rs137852619
VAR_031733
RCV000010048
CA254816
290 P>R Episodic ataxia type 6 EA6 [ClinVar, UniProt] Yes ClinGen
ClinVar
UniProt
Ensembl
dbSNP
CA3235575
RCV001157201
CA3235574
rs761842691
RCV002558372
307 M>I Episodic ataxia type 6 [ClinVar] Yes ClinGen
ExAC
TOPMed
gnomAD
ClinVar
dbSNP
rs1131691717
RCV000493629
CA359480903
RCV002524040
312 G>R Inborn genetic diseases [ClinVar] Yes ClinGen
ClinVar
TOPMed
dbSNP
CA3235583
RCV001157203
rs753136358
319 V>M Episodic ataxia type 6 [ClinVar] Yes ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
RCV000927291
CA3235588
rs200243548
RCV000298676
RCV001662328
329 A>T Episodic ataxia type 6 [ClinVar] Yes ClinGen
ClinVar
1000Genomes
ExAC
TOPMed
dbSNP
gnomAD
rs115702388
RCV001643071
RCV000713360
CA3235618
RCV000353609
385 R>H Spastic ataxia Episodic ataxia type 6 [ClinVar] Yes ClinGen
ClinVar
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
CA3235667
rs750317354
COSM3429420
RCV000713361
RCV002532952
470 A>T Variant assessed as Somatic; 0.0 impact. large_intestine Inborn genetic diseases [NCI-TCGA, Cosmic, ClinVar] Yes ClinGen
cosmic curated
ClinVar
ExAC
NCI-TCGA
TOPMed
dbSNP
gnomAD
RCV000517565
RCV002527531
RCV002525082
CA3235692
rs549164007
COSM3784881
484 V>I pancreas Inborn genetic diseases [Cosmic, ClinVar] Yes ClinGen
cosmic curated
ClinVar
1000Genomes
ExAC
TOPMed
dbSNP
gnomAD
RCV000234998
RCV000727383
rs138085358
RCV000500491
CA3235696
499 R>Q Episodic ataxia type 6 [ClinVar] Yes ClinGen
ClinVar
ESP
ExAC
TOPMed
dbSNP
gnomAD
CA3235304
rs763532936
2 T>I No ClinGen
ExAC
gnomAD
rs201337391
CA3235306
3 K>E No ClinGen
1000Genomes
ExAC
gnomAD
CA117042088
rs188661253
3 K>N No ClinGen
1000Genomes
gnomAD
CA3235308
rs143791614
5 N>K No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA3235309
rs753529094
COSM1671586
6 G>R Variant assessed as Somatic; 0.0 impact. large_intestine [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
TOPMed
gnomAD
CA117042100
rs970022233
7 E>D No ClinGen
TOPMed
gnomAD
CA359485148
rs757310275
8 E>K No ClinGen
TOPMed
rs757310275
CA117042101
8 E>Q No ClinGen
TOPMed
rs778736329
CA3235311
CA117042133
CA3235310
11 M>I No ClinGen
ExAC
gnomAD
CA359485268
rs758393528
12 G>A No ClinGen
ExAC
TOPMed
gnomAD
rs758393528
CA3235312
COSM1634212
12 G>E liver [Cosmic] No ClinGen
cosmic curated
ExAC
TOPMed
gnomAD
CA359485292
rs1201170125
13 G>D No ClinGen
gnomAD
rs1561235030
CA359485337
15 M>I No ClinGen
Ensembl
CA359485329
rs1331702692
15 M>L No ClinGen
gnomAD
CA359485353
rs1168358927
16 E>D No ClinGen
gnomAD
CA359485361
rs151121541
17 R>G No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA3235315
rs771176480
18 F>L No ClinGen
ExAC
gnomAD
rs781563049
CA3235316
20 Q>K No ClinGen
ExAC
TOPMed
gnomAD
CA3235317
rs746153813
20 Q>R No ClinGen
ExAC
gnomAD
CA359485495
rs1406951872
22 V>F No ClinGen
gnomAD
rs11543905
CA3235318
23 R>C No ClinGen
ESP
ExAC
TOPMed
gnomAD
TCGA novel 23 R>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs11543905
CA117042163
23 R>S No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA359485582
RCV000520123
rs1264331837
25 R>C No ClinGen
ClinVar
TOPMed
dbSNP
COSM592332
rs769225350
CA3235321
25 R>H lung [Cosmic] No ClinGen
cosmic curated
ExAC
TOPMed
gnomAD
TCGA novel 30 K>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs760142896
CA3235323
31 K>E No ClinGen
ExAC
gnomAD
CA359485764
rs1227515667
33 V>A No ClinGen
TOPMed
rs776251668
CA3235325
36 I>V No ClinGen
ExAC
gnomAD
TCGA novel 39 E>A Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA359485893
rs1260597532
39 E>K Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA3235328
rs745816344
COSM1067625
47 R>Q Variant assessed as Somatic; 0.0 impact. endometrium [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
gnomAD
rs138011127
CA3235331
52 L>P No ClinGen
ESP
ExAC
TOPMed
CA3235333
rs143571478
57 A>T No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs781439994
CA3235334
57 A>V No ClinGen
ExAC
TOPMed
gnomAD
CA3235335
rs555176478
59 I>T No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA3235337
rs145882647
60 V>L No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1186093229
CA359472923
61 G>V No ClinGen
gnomAD
CA117023515
rs867171256
62 T>K No ClinGen
Ensembl
CA359472924
rs1368211837
62 T>P No ClinGen
gnomAD
rs555226116
CA3235390
63 I>M No ClinGen
1000Genomes
ExAC
gnomAD
CA3235389
rs138559945
63 I>T No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA3235388
rs778250117
63 I>V No ClinGen
ExAC
gnomAD
rs779437172
CA3235391
64 L>I No ClinGen
ExAC
gnomAD
rs1579969174
CA359472940
65 G>* No ClinGen
Ensembl
CA359472955
rs1362079112
67 T>I No ClinGen
TOPMed
gnomAD
CA359472967
rs368269219
69 R>L No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs368269219
CA3235393
69 R>Q No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA117023534
rs749831415
70 P>A No ClinGen
Ensembl
rs767138995
CA117023537
70 P>L No ClinGen
Ensembl
rs761665107
CA3235395
71 Y>H No ClinGen
ExAC
TOPMed
gnomAD
CA359472980
rs1351847335
72 R>K No ClinGen
gnomAD
rs1579969329
CA359472993
73 M>I No ClinGen
Ensembl
CA3235397
rs144582794
74 S>N No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs1215123150
CA559011951
75 Y>* No ClinGen
gnomAD
TCGA novel 76 R>G Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs951918420
CA117023552
76 R>W No ClinGen
gnomAD
TCGA novel 78 V>F Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA359473031
rs1185859716
79 K>N No ClinGen
TOPMed
gnomAD
rs759754607
CA3235401
79 K>R No ClinGen
ExAC
gnomAD
CA3235402
rs765415537
80 Y>H No ClinGen
ExAC
gnomAD
rs1277311792
CA359473055
83 F>L No ClinGen
TOPMed
CA359473089
rs1157944145
88 L>V No ClinGen
gnomAD
TCGA novel 89 M>R Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA359473114
rs1454899645
91 M>I No ClinGen
TOPMed
gnomAD
rs758750828
CA3235404
91 M>T No ClinGen
ExAC
gnomAD
CA3235405
rs778125372
92 L>F No ClinGen
ExAC
gnomAD
rs779571567
CA3235408
94 M>T No ClinGen
ExAC
gnomAD
rs1374429607
COSM1162507
CA359473148
96 V>A pancreas [Cosmic] No ClinGen
cosmic curated
gnomAD
TCGA novel 100 I>F Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1359680744
CA359473177
101 I>V No ClinGen
TOPMed
CA3235411
rs778699310
102 S>C No ClinGen
ExAC
gnomAD
rs1208176336
CA359473198
104 L>V No ClinGen
gnomAD
CA359477059
rs1339365361
108 M>R No ClinGen
TOPMed
gnomAD
CA117049283
rs934526662
108 M>V No ClinGen
TOPMed
gnomAD
TCGA novel 109 A>G Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1215494602
CA359477077
109 A>V No ClinGen
gnomAD
rs1412234747
CA359477080
110 A>T No ClinGen
TOPMed
gnomAD
rs745820508
CA3235441
110 A>V No ClinGen
ExAC
TOPMed
gnomAD
rs1263050722
CA359477100
111 L>R No ClinGen
Ensembl
TCGA novel 112 D>E Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs377113494
CA117049319
112 D>G No ClinGen
ESP
gnomAD
rs34809305
CA359477144
114 K>N No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs774678500
CA3235446
116 S>P No ClinGen
ExAC
gnomAD
rs1223988110
CA359477222
120 G>R No ClinGen
TOPMed
CA359477245
CA3235447
rs762075519
121 M>I No ClinGen
ExAC
gnomAD
rs767978523
CA3235448
122 R>Q No ClinGen
ExAC
gnomAD
CA117049359
rs944912600
124 V>A No ClinGen
TOPMed
CA3235450
rs756691670
125 V>I No ClinGen
ExAC
gnomAD
CA359477337
rs1383988805
129 T>S No ClinGen
TOPMed
rs149249424
CA117049385
133 I>T No ClinGen
1000Genomes
CA3235452
COSM1067629
rs752276609
133 I>V Variant assessed as Somatic; 0.0 impact. endometrium [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
TOPMed
gnomAD
rs1432050130
CA359477402
135 V>M No ClinGen
gnomAD
rs897907910
CA117049390
136 V>L No ClinGen
TOPMed
CA359477439
rs1272447120
140 I>T No ClinGen
gnomAD
CA3235454
rs777287247
141 I>L No ClinGen
ExAC
gnomAD
TCGA novel 141 I>T Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA3235455
rs777287247
141 I>V No ClinGen
ExAC
gnomAD
CA117049408
rs140071599
142 V>I No ClinGen
ESP
TOPMed
CA359477506
rs1290549207
150 G>V No ClinGen
gnomAD
CA3235456
rs368401930
153 E>D No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1177818939
CA359477522
153 E>Q No ClinGen
TOPMed
CA359477541
rs1445927150
155 M>I Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
rs143649937
CA3235458
155 M>K No ClinGen
ESP
ExAC
gnomAD
CA117049420
rs868766252
156 H>Q No ClinGen
Ensembl
rs1216325178
CA359477556
157 R>S No ClinGen
TOPMed
gnomAD
CA3235459
rs201358917
158 E>Q No ClinGen
1000Genomes
ExAC
gnomAD
rs1167788931
CA359477568
159 G>D No ClinGen
TOPMed
rs1442530536
CA359477588
162 V>I No ClinGen
TOPMed
gnomAD
rs1442530536
CA359477586
162 V>L No ClinGen
TOPMed
gnomAD
CA3235460
RCV001090996
rs780020363
163 R>Q Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ClinVar
ExAC
NCI-TCGA
TOPMed
dbSNP
gnomAD
rs1182555011
CA359477596
164 V>M No ClinGen
TOPMed
CA3235462
rs144370200
169 A>G No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs1157071308
CA359477637
170 F>S No ClinGen
gnomAD
CA359477699
rs1263688161
177 M>I No ClinGen
gnomAD
rs1015741005
CA117051651
177 M>T No ClinGen
gnomAD
CA3235480
rs768557336
181 N>S No ClinGen
ExAC
gnomAD
CA3235481
rs779052167
182 L>M No ClinGen
ExAC
gnomAD
rs1438565133
CA359477750
185 A>G No ClinGen
gnomAD
CA359477753
rs137852620
186 C>G No ClinGen
TOPMed
rs766171404
CA3235498
193 N>S No ClinGen
ExAC
gnomAD
rs200198714
CA3235500
195 E>Q No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA359478195
rs1554045196
RCV000518021
197 R>K No ClinGen
ClinVar
Ensembl
dbSNP
rs1270068808
CA359478226
198 S>R No ClinGen
TOPMed
gnomAD
CA3235501
rs778808337
COSM342514
200 K>E lung [Cosmic] No ClinGen
cosmic curated
ExAC
gnomAD
rs1193136338
CA359478264
200 K>T No ClinGen
gnomAD
rs967451482
CA117053715
201 V>E No ClinGen
Ensembl
rs758448030
CA3235503
202 P>S No ClinGen
ExAC
gnomAD
rs778136913
CA3235504
203 I>M No ClinGen
ExAC
TOPMed
gnomAD
CA3235505
RCV000713366
rs747247810
205 A>T No ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
CA359478355
rs1303183514
205 A>V No ClinGen
gnomAD
CA117053724
rs977606863
206 N>S No ClinGen
Ensembl
CA3235507
rs541689509
207 E>K Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
1000Genomes
ExAC
NCI-TCGA
TOPMed
gnomAD
CA3235508
COSM186721
rs778074144
208 T>M large_intestine breast [Cosmic] No ClinGen
cosmic curated
ExAC
TOPMed
gnomAD
rs960180411
CA117053754
211 G>D No ClinGen
Ensembl
CA359478537
rs1182413411
216 N>S No ClinGen
gnomAD
CA359478594
rs1263115479
220 A>T No ClinGen
gnomAD
rs753687627
CA3235515
221 M>L No ClinGen
ExAC
gnomAD
CA3235516
rs754777460
221 M>T No ClinGen
ExAC
gnomAD
rs1382977672
CA359478637
222 E>Q No ClinGen
gnomAD
rs758446635
CA3235519
225 T>I No ClinGen
ExAC
gnomAD
rs202194656
COSM737919
CA3235522
226 R>Q lung Variant assessed as Somatic; 0.0 impact. endometrium [Cosmic, NCI-TCGA] No ClinGen
cosmic curated
1000Genomes
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
CA359478713
rs1436981050
227 I>N No ClinGen
gnomAD
rs919672236
CA117053863
229 E>D No ClinGen
TOPMed
rs974656218
CA117053849
RCV000517513
229 E>K No ClinGen
ClinVar
TOPMed
dbSNP
TCGA novel 230 E>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs781616140
CA3235523
230 E>K No ClinGen
ExAC
gnomAD
CA3235525
rs201623073
232 V>F No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA3235524
rs201623073
232 V>I No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
TCGA novel 233 P>Q Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA3235527
rs749768412
242 N>S No ClinGen
ExAC
gnomAD
CA117053911
rs547834086
249 F>V No ClinGen
TOPMed
rs771500129
CA3235528
250 S>C No ClinGen
ExAC
gnomAD
CA359479115
rs1261790718
251 M>L No ClinGen
gnomAD
rs772737613
CA3235529
251 M>T No ClinGen
ExAC
TOPMed
gnomAD
CA3235531
rs765991239
254 G>S No ClinGen
ExAC
TOPMed
gnomAD
CA3235532
rs776184730
256 V>A No ClinGen
ExAC
gnomAD
CA3235533
rs759370844
258 G>E No ClinGen
ExAC
gnomAD
rs907632540
CA117053930
259 N>H No ClinGen
TOPMed
CA359479255
rs1416760808
259 N>K No ClinGen
TOPMed
gnomAD
rs764999249
CA3235534
259 N>S No ClinGen
ExAC
gnomAD
rs752614435
CA3235535
260 M>V No ClinGen
ExAC
gnomAD
CA359479296
rs1412096735
262 E>K No ClinGen
gnomAD
CA359479326
rs1458712349
263 Q>R No ClinGen
gnomAD
rs763017329
CA3235536
264 G>A No ClinGen
ExAC
TOPMed
gnomAD
CA359479339
rs1321273912
264 G>R No ClinGen
gnomAD
rs751669761
CA3235538
265 Q>K No ClinGen
ExAC
gnomAD
RCV001288775
CA3235539
rs146929198
266 A>T No ClinGen
ClinVar
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
rs1390865899
CA359479415
269 E>D No ClinGen
TOPMed
gnomAD
rs867842542
CA117053993
269 E>K No ClinGen
Ensembl
CA3235540
COSM3827984
rs781475471
270 F>L Variant assessed as Somatic; 0.0 impact. breast [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
gnomAD
rs1331332370
CA359479459
272 D>E No ClinGen
gnomAD
TCGA novel 273 S>Y Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA359479488
rs1338438446
275 N>D No ClinGen
TOPMed
gnomAD
rs756447264
CA3235542
276 E>D No ClinGen
ExAC
gnomAD
rs868042440
CA117054001
276 E>K Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
Ensembl
NCI-TCGA
rs1742246958
RCV001255083
277 A>G No ClinVar
dbSNP
rs1324715225
CA359479529
278 I>V No ClinGen
TOPMed
gnomAD
CA359479548
rs1212734484
COSM1240214
279 M>T oesophagus [Cosmic] No ClinGen
cosmic curated
gnomAD
TCGA novel 279 M>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs749758915
CA3235544
281 L>P No ClinGen
ExAC
gnomAD
CA359479597
rs1251824298
283 A>T No ClinGen
gnomAD
CA359479626
rs1216202077
285 I>V No ClinGen
TOPMed
CA3235545
rs769171398
286 M>I No ClinGen
ExAC
TOPMed
gnomAD
rs111234265
CA117055625
288 Y>C No ClinGen
Ensembl
rs1372687512
CA359480457
289 A>T No ClinGen
gnomAD
rs1422798593
CA359480477
289 A>V No ClinGen
gnomAD
rs143438887
CA3235569
291 V>M No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA3235570
rs368824428
294 L>H No ClinGen
ESP
ExAC
gnomAD
CA359480562
rs368824428
294 L>P No ClinGen
ESP
ExAC
gnomAD
rs762834661
CA3235571
299 G>A No ClinGen
ExAC
TOPMed
gnomAD
CA359480702
CA359480699
rs1297834327
300 K>N No ClinGen
gnomAD
TCGA novel 303 E>D Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1325669692
CA359480785
306 D>N No ClinGen
gnomAD
rs774369059
CA3235573
307 M>T No ClinGen
ExAC
gnomAD
CA359480845
rs1290342061
308 G>R No ClinGen
TOPMed
gnomAD
CA359480827
rs1290342061
308 G>S No ClinGen
TOPMed
gnomAD
rs1451693427
CA359480856
309 V>M No ClinGen
TOPMed
gnomAD
rs372652402
CA3235576
310 I>T No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs766481298
CA3235579
311 G>R No ClinGen
ExAC
gnomAD
rs1273411490
CA359480897
311 G>V No ClinGen
TOPMed
rs771876749 313 Q>A Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No NCI-TCGA
rs966200792
CA117055715
314 L>I No ClinGen
TOPMed
gnomAD
rs1189034701
CA359480971
315 A>V No ClinGen
gnomAD
CA3235581
rs117588697
318 T>A No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA359481033
rs1355519406
319 V>A No ClinGen
TOPMed
COSM164362
rs758850515
CA3235584
321 V>I breast [Cosmic] No ClinGen
cosmic curated
ExAC
gnomAD
rs778392080
CA3235585
322 I>V No ClinGen
ExAC
TCGA novel 323 V>A Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA359481093
rs1288447514
323 V>I No ClinGen
gnomAD
rs147552203
CA3235586
328 H>R No ClinGen
ESP
ExAC
TOPMed
rs559402074
CA3235589
331 I>V No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA3235591
rs774323789
332 V>I No ClinGen
ExAC
TOPMed
gnomAD
rs748053114
CA3235592
335 L>F No ClinGen
ExAC
TOPMed
gnomAD
CA3235593
rs780762087
342 R>Q No ClinGen
ExAC
TOPMed
gnomAD
CA359481405
rs1229578292
COSM1067633
342 R>W Variant assessed as Somatic; 0.0 impact. large_intestine endometrium [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
NCI-TCGA
TOPMed
gnomAD
CA359481454
rs926634917
344 N>K No ClinGen
TOPMed
gnomAD
CA359481457
rs1209314098
345 P>A No ClinGen
gnomAD
CA359481467
rs1249591144
346 W>R No ClinGen
gnomAD
rs773243452
CA3235594
348 F>L No ClinGen
ExAC
gnomAD
CA359481525
rs1183210247
349 I>F No ClinGen
gnomAD
rs760669339
RCV001288766
CA3235595
349 I>T No ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
CA359481565
rs1580044991
352 L>V No ClinGen
Ensembl
CA3235600
RCV000518716
rs532925070
357 I>V No ClinGen
ClinVar
1000Genomes
ExAC
TOPMed
dbSNP
gnomAD
rs373692891
CA3235602
359 A>T No ClinGen
ESP
ExAC
TOPMed
gnomAD
TCGA novel 359 A>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA359481865
rs1404285547
366 S>A No ClinGen
TOPMed
gnomAD
CA359481869
rs1288868855
366 S>F No ClinGen
TOPMed
gnomAD
rs762054481
CA117056290
367 A>T No ClinGen
Ensembl
rs746980992
CA3235612
367 A>V No ClinGen
ExAC
CA359481952
rs1319055603
372 T>N No ClinGen
Ensembl
rs1409974399
CA359482102
378 E>D No ClinGen
gnomAD
rs927051271
CA117056315
378 E>Q No ClinGen
TOPMed
rs145843572
CA3235613
379 N>K No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs199787096
COSM186725
CA3235615
382 V>M Variant assessed as Somatic; 0.0 impact. large_intestine [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
1000Genomes
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
rs1346862815
CA359482262
384 K>T No ClinGen
gnomAD
CA3235617
rs376919175
385 R>C No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs376919175
CA117056356
385 R>S No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs369119814
CA3235620
386 V>I Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
1000Genomes
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
CA359482339
rs1253331576
388 R>G No ClinGen
TOPMed
gnomAD
rs762409451
CA3235621
COSM1067635
389 F>L endometrium [Cosmic] No ClinGen
cosmic curated
ExAC
TOPMed
gnomAD
rs1200209870
CA359482393
390 V>M No ClinGen
TOPMed
gnomAD
rs1580046472
CA359482436
391 L>P No ClinGen
Ensembl
CA3235626
rs549250283
393 V>I No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA3235627
rs561243426
394 G>E Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
1000Genomes
ExAC
NCI-TCGA
gnomAD
CA117056408
rs997928477
395 A>D No ClinGen
Ensembl
CA359482541
rs1580046525
395 A>P No ClinGen
Ensembl
CA359482598
rs1386076563
397 I>M No ClinGen
gnomAD
CA3235628
rs777628859
397 I>T No ClinGen
ExAC
gnomAD
rs1290009650
CA359482622
398 N>K No ClinGen
TOPMed
TCGA novel 400 D>H Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA359482725
rs1181267359
401 G>E No ClinGen
gnomAD
rs1301908420
CA359482688
401 G>R No ClinGen
gnomAD
rs1369065288
CA359482785
405 Y>H No ClinGen
gnomAD
CA3235630
rs770833613
406 E>G No ClinGen
ExAC
TCGA novel 408 L>W Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs781147237
CA3235631
413 I>M No ClinGen
ExAC
gnomAD
rs1343082422
CA359483079
417 N>K No ClinGen
gnomAD
RCV000993019
CA3235632
rs745942837
420 E>G No ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
CA3235633
rs769918067
421 L>V No ClinGen
ExAC
gnomAD
rs1383191215
CA359483281
424 G>R No ClinGen
TOPMed
gnomAD
rs1280991277
CA359483310
424 G>V No ClinGen
TOPMed
CA359483372
rs1210946703
427 I>V No ClinGen
gnomAD
rs763237927
CA3235635
428 T>I No ClinGen
ExAC
TOPMed
gnomAD
rs1391192851
CA359483414
RCV000516644
429 I>V No ClinGen
ClinVar
TOPMed
dbSNP
gnomAD
rs1301585140
CA359609721
432 T>I No ClinGen
TOPMed
rs1742538697
RCV001351307
434 T>I No ClinVar
dbSNP
CA359609740
rs1443318401
435 A>V No ClinGen
TOPMed
rs947894847
CA117427162
440 A>E No ClinGen
Ensembl
CA3235654
rs768904432
443 I>V No ClinGen
ExAC
gnomAD
CA117427163
COSM592322
rs1038146073
446 A>E lung Variant assessed as Somatic; impact. [Cosmic, NCI-TCGA] No ClinGen
cosmic curated
NCI-TCGA
gnomAD
CA359609809
rs1038146073
446 A>V Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
TCGA novel 451 M>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA3235658
rs773798737
451 M>V No ClinGen
ExAC
gnomAD
CA3235659
rs181358295
458 V>I No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA3235660
rs764612898
459 G>S No ClinGen
ExAC
TOPMed
gnomAD
rs1255797502
CA359609900
462 T>A No ClinGen
gnomAD
CA3235662
rs201331191
464 D>N No ClinGen
ExAC
TOPMed
gnomAD
rs763798684
CA3235663
466 T>M Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
rs763798684
CA3235664
466 T>R No ClinGen
ExAC
TOPMed
gnomAD
rs762460017
CA117427166
468 I>M No ClinGen
Ensembl
CA3235666
rs767300506
469 I>V No ClinGen
ExAC
gnomAD
rs756063867
CA3235668
470 A>V No ClinGen
ExAC
gnomAD
rs968582080
CA117427167
471 V>E No ClinGen
TOPMed
rs1205623410
CA359609978
474 F>S No ClinGen
TOPMed
rs766340486
CA3235686
COSM1695612
477 R>C Variant assessed as Somatic; impact. skin [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
TOPMed
gnomAD
rs753780652
CA3235688
477 R>H No ClinGen
ExAC
TOPMed
gnomAD
CA3235687
rs753780652
477 R>P No ClinGen
ExAC
TOPMed
gnomAD
rs766340486
CA359610011
477 R>S No ClinGen
ExAC
TOPMed
gnomAD
rs1339572246
CA359610015
478 L>I No ClinGen
gnomAD
CA359610020
rs1561288563
RCV000713362
COSM1226002
479 R>W oesophagus large_intestine Variant assessed as Somatic; impact. [Cosmic, NCI-TCGA] No ClinGen
cosmic curated
ClinVar
Ensembl
NCI-TCGA
dbSNP
TCGA novel 482 T>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA359610037
rs1167208574
482 T>S No ClinGen
gnomAD
CA3235690
rs748343069
483 N>S No ClinGen
ExAC
gnomAD
rs549164007
CA359610049
484 V>L No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA359610089
rs1192752005
490 G>V No ClinGen
gnomAD
rs1334091499
CA359610096
492 G>R No ClinGen
gnomAD
TCGA novel 494 V>A Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA359610115
rs1449022570
495 E>K Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA3235695
rs371888623
COSM186726
499 R>* large_intestine [Cosmic] No ClinGen
cosmic curated
ESP
ExAC
gnomAD
rs1332218670
CA359610149
500 H>Y No ClinGen
TOPMed
rs768168646
CA3235697
504 N>S No ClinGen
ExAC
gnomAD
TCGA novel 506 D>C Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs773871568
CA3235698
506 D>N No ClinGen
ExAC
gnomAD
CA3235699
rs375611408
507 V>A No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA3235700
rs771678103
509 M>K No ClinGen
ExAC
TOPMed
gnomAD
rs771678103
CA359610214
509 M>T No ClinGen
ExAC
TOPMed
gnomAD
CA359610233
rs1364928922
512 S>P No ClinGen
gnomAD
rs1433825221
CA359610239
513 V>L No ClinGen
gnomAD
rs763377985
CA3235701
515 E>G No ClinGen
ExAC
gnomAD
TCGA novel 516 E>G Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 517 N>Y Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA359610315
rs1226153453
523 Y>H No ClinGen
gnomAD
rs757416748
CA3235702
526 I>T No ClinGen
ExAC
TOPMed
gnomAD
rs766104399
CA3235703
528 Q>* No ClinGen
ExAC
gnomAD
rs753745170
CA3235704
530 N>S No ClinGen
ExAC
TOPMed
gnomAD
CA3235706
rs765361839
532 T>N No ClinGen
ExAC
gnomAD
rs1580053666
CA359610381
533 E>K No ClinGen
Ensembl
CA359610401
rs1227389534
535 P>H No ClinGen
TOPMed
gnomAD
rs1227389534
CA359610402
535 P>R No ClinGen
TOPMed
gnomAD
rs1045623880
CA117427389
537 D>N No ClinGen
TOPMed
gnomAD
RCV000517043
CA3235707
rs752803485
538 S>C No ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
rs1202617907
CA359610442
541 K>R No ClinGen
TOPMed
CA117427390
rs1001501963
542 M>I No ClinGen
TOPMed
CA359610450
rs1414663352
542 M>T No ClinGen
gnomAD

1 associated diseases with P43003

[MIM: 612656]: Episodic ataxia 6 (EA6)

A disorder characterized by episodic ataxia, seizures, migraine and alternating hemiplegia. {ECO:0000269|PubMed:16116111}. Note=The disease is caused by variants affecting the gene represented in this entry.

Without disease ID
  • A disorder characterized by episodic ataxia, seizures, migraine and alternating hemiplegia. {ECO:0000269|PubMed:16116111}. Note=The disease is caused by variants affecting the gene represented in this entry.

2 regional properties for P43003

Type Name Position InterPro Accession
conserved_site Sodium:dicarboxylate symporter, conserved site 84 - 98 IPR018107-1
conserved_site Sodium:dicarboxylate symporter, conserved site 392 - 415 IPR018107-2

Functions

Description
EC Number
Subcellular Localization
  • Cell membrane ; Multi-pass membrane protein
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

11 GO annotations of cellular component

Name Definition
basal plasma membrane The region of the plasma membrane located at the basal end of the cell. Often used in reference to animal polarized epithelial membranes, where the basal membrane is the part attached to the extracellular matrix, or in plant cells, where the basal membrane is defined with respect to the zygotic axis.
cell surface The external part of the cell wall and/or plasma membrane.
cytoplasmic vesicle A vesicle found in the cytoplasm of a cell.
integral component of plasma membrane The component of the plasma membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
membrane A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
membrane protein complex Any protein complex that is part of a membrane.
neuron projection A prolongation or process extending from a nerve cell, e.g. an axon or dendrite.
neuronal cell body The portion of a neuron that includes the nucleus, but excludes cell projections such as axons and dendrites.
perinuclear region of cytoplasm Cytoplasm situated near, or occurring around, the nucleus.
plasma membrane The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
synapse The junction between an axon of one neuron and a dendrite of another neuron, a muscle fiber or a glial cell. As the axon approaches the synapse it enlarges into a specialized structure, the presynaptic terminal bouton, which contains mitochondria and synaptic vesicles. At the tip of the terminal bouton is the presynaptic membrane; facing it, and separated from it by a minute cleft (the synaptic cleft) is a specialized area of membrane on the receiving cell, known as the postsynaptic membrane. In response to the arrival of nerve impulses, the presynaptic terminal bouton secretes molecules of neurotransmitters into the synaptic cleft. These diffuse across the cleft and transmit the signal to the postsynaptic membrane.

6 GO annotations of molecular function

Name Definition
glutamate binding Binding to glutamate, the anion of 2-aminopentanedioic acid.
glutamate:sodium symporter activity Enables the transfer of a solute or solutes from one side of a membrane to the other according to the reaction: glutamate(out) + Na+(out) = glutamate(in) + Na+(in).
high-affinity L-glutamate transmembrane transporter activity Enables the transfer of glutamate from one side of a membrane to the other. In high-affinity transport the transporter is able to bind the solute even if it is only present at very low concentrations.
L-glutamate transmembrane transporter activity Enables the transfer of L-glutamate from one side of a membrane to the other. L-glutamate is the anion of 2-aminopentanedioic acid.
metal ion binding Binding to a metal ion.
neutral amino acid transmembrane transporter activity Enables the transfer of neutral amino acids from one side of a membrane to the other. Neutral amino acids have side chains with no charge at pH 7.3.

26 GO annotations of biological process

Name Definition
auditory behavior The behavior of an organism in response to a sound.
cell morphogenesis involved in neuron differentiation The process in which the structures of a neuron are generated and organized. This process occurs while the initially relatively unspecialized cell is acquiring the specialized features of a neuron.
cellular response to cocaine Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cocaine stimulus. Cocaine is a crystalline alkaloid obtained from the leaves of the coca plant.
cellular sodium ion homeostasis Any process involved in the maintenance of an internal steady state of sodium ions at the level of a cell.
chemical synaptic transmission The vesicular release of classical neurotransmitter molecules from a presynapse, across a chemical synapse, the subsequent activation of neurotransmitter receptors at the postsynapse of a target cell (neuron, muscle, or secretory cell) and the effects of this activation on the postsynaptic membrane potential and ionic composition of the postsynaptic cytosol. This process encompasses both spontaneous and evoked release of neurotransmitter and all parts of synaptic vesicle exocytosis. Evoked transmission starts with the arrival of an action potential at the presynapse.
chloride transmembrane transport The process in which chloride is transported across a membrane.
cranial nerve development The process whose specific outcome is the progression of the cranial nerves over time, from its formation to the mature structure. The cranial nerves are composed of twelve pairs of nerves that emanate from the nervous tissue of the hindbrain. These nerves are sensory, motor, or mixed in nature, and provide the motor and general sensory innervation of the head, neck and viscera. They mediate vision, hearing, olfaction and taste and carry the parasympathetic innervation of the autonomic ganglia that control visceral functions.
D-aspartate import across plasma membrane The directed import of D-aspartate from the extracellular region across the plasma membrane and into the cytosol.
gamma-aminobutyric acid biosynthetic process The chemical reactions and pathways resulting in the formation of gamma-aminobutyric acid (GABA, 4-aminobutyrate), an amino acid which acts as a neurotransmitter in some organisms.
ion transport The directed movement of charged atoms or small charged molecules into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
L-aspartate import across plasma membrane The directed movement of L-aspartate from outside of a cell, across the plasma membrane and into the cytosol.
L-glutamate import The directed movement of L-glutamate, the L-enantiomer of the anion of 2-aminopentanedioic acid, into a cell or organelle.
L-glutamate import across plasma membrane The directed movement of L-glutamate from outside of a cell, across the plasma membrane and into the cytosol.
L-glutamate transmembrane transport The directed movement of L-glutamate across a membrane.
neuromuscular process controlling balance Any process that an organism uses to control its balance, the orientation of the organism (or the head of the organism) in relation to the source of gravity. In humans and animals, balance is perceived through visual cues, the labyrinth system of the inner ears and information from skin pressure receptors and muscle and joint receptors.
neurotransmitter transport The directed movement of a neurotransmitter into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. Neurotransmitters are any chemical substance that is capable of transmitting (or inhibiting the transmission of) a nerve impulse from a neuron to another cell.
neurotransmitter uptake The directed movement of neurotransmitters into neurons or glial cells. This process leads to inactivation and recycling of neurotransmitters.
positive regulation of synaptic transmission Any process that activates or increases the frequency, rate or extent of synaptic transmission, the process of communication from a neuron to a target (neuron, muscle, or secretory cell) across a synapse.
potassium ion transmembrane transport A process in which a potassium ion is transported from one side of a membrane to the other.
response to antibiotic Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an antibiotic stimulus. An antibiotic is a chemical substance produced by a microorganism which has the capacity to inhibit the growth of or to kill other microorganisms.
response to light stimulus Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a light stimulus, electromagnetic radiation of wavelengths classified as infrared, visible or ultraviolet light.
response to wounding Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating damage to the organism.
response to xenobiotic stimulus Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus from a xenobiotic, a compound foreign to the organim exposed to it. It may be synthesized by another organism (like ampicilin) or it can be a synthetic chemical.
sensory perception of sound The series of events required for an organism to receive an auditory stimulus, convert it to a molecular signal, and recognize and characterize the signal. Sonic stimuli are detected in the form of vibrations and are processed to form a sound.
transepithelial transport The directed movement of a substance from one side of an epithelium to the other.
transport across blood-brain barrier The directed movement of substances (e.g. macromolecules, small molecules, ions) through the blood-brain barrier.

6 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
P46411 SLC1A3 Excitatory amino acid transporter 1 Bos taurus (Bovine) PR
O00341 SLC1A7 Excitatory amino acid transporter 5 Homo sapiens (Human) PR
O35544 Slc1a6 Excitatory amino acid transporter 4 Mus musculus (Mouse) PR
Q8JZR4 Slc1a7 Excitatory amino acid transporter 5 Mus musculus (Mouse) PR
P56564 Slc1a3 Excitatory amino acid transporter 1 Mus musculus (Mouse) PR
P24942 Slc1a3 Excitatory amino acid transporter 1 Rattus norvegicus (Rat) PR
10 20 30 40 50 60
MTKSNGEEPK MGGRMERFQQ GVRKRTLLAK KKVQNITKED VKSYLFRNAF VLLTVTAVIV
70 80 90 100 110 120
GTILGFTLRP YRMSYREVKY FSFPGELLMR MLQMLVLPLI ISSLVTGMAA LDSKASGKMG
130 140 150 160 170 180
MRAVVYYMTT TIIAVVIGII IVIIIHPGKG TKENMHREGK IVRVTAADAF LDLIRNMFPP
190 200 210 220 230 240
NLVEACFKQF KTNYEKRSFK VPIQANETLV GAVINNVSEA METLTRITEE LVPVPGSVNG
250 260 270 280 290 300
VNALGLVVFS MCFGFVIGNM KEQGQALREF FDSLNEAIMR LVAVIMWYAP VGILFLIAGK
310 320 330 340 350 360
IVEMEDMGVI GGQLAMYTVT VIVGLLIHAV IVLPLLYFLV TRKNPWVFIG GLLQALITAL
370 380 390 400 410 420
GTSSSSATLP ITFKCLEENN GVDKRVTRFV LPVGATINMD GTALYEALAA IFIAQVNNFE
430 440 450 460 470 480
LNFGQIITIS ITATAASIGA AGIPQAGLVT MVIVLTSVGL PTDDITLIIA VDWFLDRLRT
490 500 510 520 530 540
TTNVLGDSLG AGIVEHLSRH ELKNRDVEMG NSVIEENEMK KPYQLIAQDN ETEKPIDSET
KM